| Literature DB >> 27849259 |
Maria Zildany P Távora-Mehta1, Niraj Mehta1, Adriano Magajevski1, Larissa de Oliveira1, Débora Lee Smith Maluf1, Letícia Concato1, Eduardo Doubrawa1, Márcio Rogério Ortiz1, Cláudio L Pereira da Cunha1.
Abstract
BACKGROUND: Orthostatic intolerance patients' pathophysiological mechanism is still obscure, contributing to the difficulty in their clinical management.Entities:
Mesh:
Year: 2016 PMID: 27849259 PMCID: PMC5102482 DOI: 10.5935/abc.20160135
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Non-invasive hemodynamic index monitor records. A) Patient in Group I – observe the compensatory elevation of TPVR index during inclination. B) Patient in Group II – observe the unexpected drop in TPVR during inclination.
Group homogeneity evaluation in relation to age, weight, height, body mass index and body surface
| Variable | Group | Nº | Mean | Median | Minimum | Maximum | Standard | p value |
|---|---|---|---|---|---|---|---|---|
| I | 33 | 56.2 | 58.0 | 18.7 | 90.2 | 16.9 | ||
| II | 28 | 57.4 | 61.6 | 16.2 | 86.9 | 22.6 | ||
| Control | 24 | 27.6 | 28.5 | 17.0 | 39.0 | 6.2 | <0.001 | |
| Height (cm) | I | 33 | 165.5 | 165.0 | 150.0 | 182.0 | 7.8 | |
| II | 28 | 168.4 | 168.5 | 151.0 | 190.0 | 8.9 | ||
| Control | 24 | 170.2 | 169.0 | 152.0 | 192.0 | 10.9 | 0.161 | |
| Weight (kg) | I | 33 | 70.6 | 71.0 | 47.0 | 110.0 | 12.6 | |
| II | 28 | 75.3 | 75.0 | 50.0 | 109.0 | 15.4 | ||
| Control | 24 | 71.5 | 68.5 | 49.0 | 118.0 | 15.5 | 0.433 | |
| Body mass index | I | 33 | 25.7 | 26.1 | 18.4 | 33.2 | 3.4 | |
| (kg/m2) | II | 28 | 26.6 | 26.3 | 18.8 | 36.0 | 5.1 | |
| Control | 24 | 24.4 | 24.2 | 20.1 | 32.0 | 3.0 | 0.157 | |
| Body surface (cm2) | I | 33 | 1778.0 | 1765.0 | 1462.0 | 2304.0 | 182.2 | |
| II | 28 | 1845.6 | 1853.0 | 1467.0 | 2283.0 | 196.5 | ||
| Control | 24 | 1739.3 | 1757.0 | 642.0 | 2468.0 | 361.0 | 0.298 |
ANOVA with p<0.05 factor
Hemodynamic parameters (mean SD) in the supine position and during tilt 10' and tilt 20' in the drug-free phase
| Group I (I) | Group II (II) | Control (C) | p value | p value | p value | p value | |
|---|---|---|---|---|---|---|---|
| HR Supine | 69.5±11 | 70.0±11.7 | 70.4±9.7 | 0.63 | - | - | - |
| MBP Supine | 96.6±11.4 | 97.7±15.7 | 84±8.7 | 0.13 | - | - | - |
| SV Supine | 81.8±14.8 | 66.4±14.9 | 101.5±24.2 | <0.001 | 0.001 | <0.001 | <0.001 |
| CD Supine | 5.71±1.57 | 4.53±0.81 | 6.95±1.56 | <0.001 | <0.001 | <0.001 | <0.001 |
| TPVR Supine | 1424±404 | 1750±442 | 974.4±230 | <0.001 | <0.001 | <0.001 | <0.001 |
p value adjusted for age (ANCOVA)
TPVR in dyne.seg/cm5
HR: heart rate; MBP: mean blood pressure; SV: systolic volume; CD: cardiac debit; TPVR: total peripheral vascular resistance.
Figure 2A and B) Means and confidence intervals of 95% for SV and CD means adjusted for age: comparison between the groups at each moment of analysis (supine, tilt 10' and tilt 20'). SV: systolic volume; CD: cardiac debit.
Figure 3Means and confidence intervals of 95% for TPVR means adjusted for age: comparison between the groups at each moment of analysis (supine, tilt 10' and tilt 20').
Figure 4A and B) Means and confidence intervals of MBP and HR means adjusted for age: comparison between the groups at each moment of analysis (supine, tilt 10' and tilt 20'). MBP: mean blood pressure; HR: heart rate.
Difference of hemodynamic parameters (mean ± SD) between the periods of tilt' 10' and supine position (∆ 10'-S) and between the period tilt 20' and supine position (∆ 20'-S)
| Group I | Group II | Control (C) | (I x II) p | (I x C) p | (II x C) p | |
|---|---|---|---|---|---|---|
| HR (bpm) (∆10'-S) | 8.8±7.2 | 10.3±7.8 | 16.8±6.6 | NS | NS | NS |
| SV (ml) (∆10'-S) | -16.3±12.1 | -2.2±11.2 | -18.8±18.4 | <0.001 | 0.50 | <0.001 |
| TPVR | 301±218 | -174±328 | 180±260 | <0.001 | 0.09 | <0.001 |
| MBP (mmHg) (∆10'-S) | 9.1±8.6 | 1.7±15.4 | 18.1±9.4 | 0.010 | 0.003 | <0.001 |
p value adjusted for age (ANCOVA).
TPVR in dyne.seg/cm5
HR: heart rate; MBP: mean blood pressure; SV: systolic volume; TPVR: total peripheral vascular resistance.
Figure 5a (Group I), b (Group II) and c (Control group). Scatter diagrams for SV and TPVR at 10' during tilt test; r: Pearson correlation coefficient. SV: systolic volume;TPVR: total peripheral vascular resistance.